Abstract:<bold>Background</bold>: The ratio of fibrinogen to gamma-glutamine transferase (FGR) was used to predict long-term prognosis in patients with coronary heart disease (CHD). <bold>Methods</bold>: A total of 5638 patients with CHD who were hospitalized from January 2008 to December 2016 were retrospectively enrolled in the study. The mean follow-up time was 35.9 +/-+/- 22.5 months. The follow-up endpoints were major cardiac and cerebrovascular adverse events (MACCE). The optimal FGR cut-off value was determined and divided into high- and low-FGR groups according to the receiver operating characteristic (ROC) curve. Statistical methods were used to compare the differences between the two groups and their prognoses to determine whether FGR can predict prognosis in patients with CHD. The traditional predictors were incorporated into the logistic regression model to observe the correlation between these indicators and all-cause mortality (ACM) events. We compared the prediction performance of FGR and traditional predictors on the occurrence of ACM events by ROC curves. <bold>Results</bold>: The optimal cut-off value was determined via a ROC analysis (FGR = 1.22, p = 0.002), and subjects were classified into high and low FGR groups. The follow-up found that the incidence of MACCE in the high FGR group was higher than that in the low FGR group. The COX multivariate regression model showed that high FGR was independently correlated with the occurrence of MACCE. In addition, the Kaplan-Meier survival curve showed that the risk of events was significantly increased in the group with high FGR. With increases in the FGR ratio, the risk of MACCE was increased. The ROC curve revealed that the risk of ACM was statistically different between the FGR and the traditional risk factor model (p = 0.002), (Fibrinogen (p = 0.008), gamma-glutamine transferase (GGT) (p = 0.004), and N-terminal pro brain natriuretic peptide (NT-ProBNP) (p = 0.024)). The comparison between other different models were not statistically significant (p >> 0.05). The area under the FGR model curve was larger than that of the traditional risk factors, fibrinogen, GGT and NT-ProBNP models. <bold>Conclusions</bold>: High FGR can increase the risk of MACCE in patients with CHD; additionally, it can be used as a new biomarker for long-term prognosis in CHD patients.

The Predictive Value of Serum Advanced Fibrinogen and Uric Acid for Acute Coronary Event Risk

Predictive Value of Plasma Fibrinogen Levels in Patients Admitted for Acute Coronary Syndrome

The study on the relationship between the level of serum CysC and atrial fibrillation in patients with acute cerebral infarction

Correlation Between Serum Uric Acid Levels and Coronary Plaque Characteristics on Optical Coherence Tomography.

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Predictive Value of Homocysteine and Serum Ferritin for Coronary Heart Disease

Value of fibrinogen in predicting long-term cardiovascular events in patients with acute coronary syndrome after intervention treatment

New Insights into the Association Between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: an Intravascular Optical Coherence Tomography Study

[The Relationship Between Hyperfibrinogenemia and Severity of Coronary Heart Disease].

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

Impact of lipoprotein(a) and fibrinogen on prognosis in patients with coronary artery disease: A retrospective cohort study

Predictive Value of the Fibrinogen to Gamma-Glutamine Transferase Ratio in the Long-Term Outcome in Patients with Coronary Heart Disease: A Retrospective Cohort Study

Hyperuricemia and hypertriglyceridemia in acute coronary event risk

Significance of Predicting Prognosis about Level of Fibrinogen,d-Dimer in Unstable Angina Before Percutaneous Coronary Intervention

Prediction of Acute Kidney Injury after Coronary Artery Bypass Graft from Preoperative Serum Uric Acid

A high level of uric acid is associated with long-term adverse cardiovascular outcomes in patients who received fractional flow reserve with coronary intermediate stenosis

The analysis of relationship between uric acid and coronary heart disease

The predictive value of serum fibrinogen and platelet distribution width for long-term cardiac death in acute myocardial infarction patients

Urinary Fibrinogen As a Predictor of Progression of CKD

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study